Fundraising Fox

Neuros Medical

Aliso Viejo, US · Delaware corporation · 8 known investors

neurosmedical.com ↗

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device for managing chronic phantom limb pain and residual limb pain in adults with lower limb loss. The patient-controlled device delivers electrical stimulation directly to the pain source and can be activated on-demand via a handheld controller.

BiotechHealthtechMedical Devices

Founders & leadership

DV
David VeinoPresident, Chief Executive Officer, and Secretary
JE
Joyce EronyDirector
WH
William HarringtonDirector
FA
Fouad AzzamDirector
ZS
Zach StassenChief Financial Officer
MM
Marc-Andre MarcotteDirector
RB
Randy BanDirector
CR
Claiborne R. RankinDirector
RJ
Robert J. CentaChief Financial Officer
JJ
Joseph J. JankowskiDirector
SF
Scott F. DreesDirector
JJ
Jon J. SnyderDirector, President, Secretary and CEO

Investors · 8

Amzak HealthNew York
APERTURE Venture PartnersBoston · $1M – $5M
CWRU Technology VenturesCleveland · $50K – $250K
iSelect FundSt. Louis · $250K – $2M
JobsOhio VenturesColumbus
Jumpstart VenturesCleveland · $500K – $2M
RiverVest Venture PartnersSt. Louis · $500K – $3M
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board

Reported raises · per SEC filings

Form D private placements
▶$56MraisedAug 2025 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David VeinoExecutive Officer, Director
  • Joyce EronyDirector
  • William HarringtonDirector
  • Fouad AzzamDirector
  • Zach StassenExecutive Officer
  • Casey TanseyDirector
  • Marc-Andre MarcotteDirector
  • Randy BanDirector
Offering amount
$65M
Amount sold
$56M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedSep 2023 · 41 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HarringtonDirector
  • Marc-Andre MarcotteDirector
  • Casey TanseyDirector
  • Anthony NataleDirector
  • Thomas C. WilderExecutive Officer, Director
  • Joyce EronyDirector
Offering amount
$20M
Amount sold
$20M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.2MraisedDec 2022 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joyce EronyDirector
  • Thomas C. WilderExecutive Officer, Director
  • William HarringtonDirector
  • Anthony NataleDirector
  • Casey TanseyDirector
  • Marc-Andre MarcotteDirector
Offering amount
$10M
Amount sold
$8.2M
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37MraisedNov 2020 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas C. WilderExecutive Officer, Director
  • Casey TanseyDirector
  • William HarringtonDirector
  • Anthony NataleDirector
  • Marc-Andre MarcotteDirector
  • Joyce EronyDirector
Offering amount
$42.8M
Amount sold
$37M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedJun 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HarringtonDirector
  • Casey TanseyDirector
  • Thomas C. WilderExecutive Officer, Director
  • Anthony NataleDirector
Offering amount
$5.5M
Amount sold
$2.2M
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedOct 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas C. WilderExecutive Officer, Director
  • William HarringtonDirector
  • Casey TanseyDirector
  • Anthony NataleDirector
Offering amount
$9.2M
Amount sold
$2.4M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedAug 2017 · 55 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Anthony NataleDirector
  • William HarringtonDirector
  • Casey TanseyDirector
  • Jon J. SnyderExecutive Officer, Director
  • Alan KaganovDirector
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$22.6MraisedAug 2017 · 27 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Anthony NataleDirector
  • Alan KaganovDirector
  • William HarringtonDirector
  • Jon J. SnyderExecutive Officer, Director
  • Casey TanseyDirector
Offering amount
$22.7M
Amount sold
$22.6M
Minimum investment
$16.7K
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news